ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1318

Clinical Utility of Ultrasonography (US) in Diagnosing and Monitoring Disease Activity of Relapsing Polychondritis (RP) and Comparison of Cartilaginous US Findings between RP, Repeated Trauma and Healthy Subjects

Satoshi Inotani1 and Yoshinori Taniguchi2, 1Endocrinology, Metabolism, Nephrology and Rheumatology, Kochi Medical School, Kochi, Japan, 2Endocrinology, Metabolism,Nephrology and Rheumatology, Kochi University, Kochi, Japan

Meeting: 2018 ACR/ARHP Annual Meeting

Keywords: polychondritis and ultrasonography

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, October 22, 2018

Title: Miscellaneous Rheumatic and Inflammatory Diseases Poster II: Interstitial Lung Disease, Still's Disease, FMF, Polychondritis

Session Type: ACR Poster Session B

Session Time: 9:00AM-11:00AM

Background/Purpose: Relapsing polychondritis (RP) is a rare systemic inflammatory disorder, and the diagnosis and treatment evaluation are often difficult. Therefore, the discovery of more convenient imaging modality than contrast-CT, MRI and FDG-PET/CT would be required on diagnosis and treatment.To assess the clinical utility of ultrasonography (US) in diagnosing and monitoring disease activity of relapsing polychondritis (RP).

Methods: Auricular and nasal chondritis of patients with RP (n=6) were initially assessed by US before and after treatments. Secondly, the changes of US findings and serum inflammatory markers were compared in RP. Finally, the auricular and nasal US findings between patients with RP (n=6), repeated trauma (n=6) which finding is similar to RP, and healthy subjects (n=6) were examined comparatively.

Results: In all cases of RP, US finding before treatment showed low-echoic swollen auricular and nasal cartilage with increased power Doppler signals (PDS), corresponding to biopsy findings. After treatment with prednisolone (PSL) combined with methotrexate, the swollen ear and nose completely resolved. Then, swollen cartilage on US also dramatically reduced with the decrease of PDS. When serum inflammatory markers completely improved, but PDS remained in 2 of 6 cases, and these cases showed flare due to early PSL tapering. Finally, the cartilage of RP on US could be apparently differentiated from repeated trauma and healthy subject due to thickness of cartilage, PDS and subperichondrial serous effusion.

Conclusion: Assessment of RP lesions by US possibly facilitates evaluation of cartilaginous lesions and monitoring of disease activity, especially when we consider the treatment response and the timing of drug tapering.


Disclosure: S. Inotani, None; Y. Taniguchi, None.

To cite this abstract in AMA style:

Inotani S, Taniguchi Y. Clinical Utility of Ultrasonography (US) in Diagnosing and Monitoring Disease Activity of Relapsing Polychondritis (RP) and Comparison of Cartilaginous US Findings between RP, Repeated Trauma and Healthy Subjects [abstract]. Arthritis Rheumatol. 2018; 70 (suppl 9). https://acrabstracts.org/abstract/clinical-utility-of-ultrasonography-us-in-diagnosing-and-monitoring-disease-activity-of-relapsing-polychondritis-rp-and-comparison-of-cartilaginous-us-findings-between-rp-repeated-trauma-and-heal/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2018 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/clinical-utility-of-ultrasonography-us-in-diagnosing-and-monitoring-disease-activity-of-relapsing-polychondritis-rp-and-comparison-of-cartilaginous-us-findings-between-rp-repeated-trauma-and-heal/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology